Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Artemisinin Antimalarial Drugs
1.2 Key Market Segments
1.2.1 Artemisinin Antimalarial Drugs Segment by Type
1.2.2 Artemisinin Antimalarial Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Artemisinin Antimalarial Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Artemisinin Antimalarial Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Artemisinin Antimalarial Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Artemisinin Antimalarial Drugs Market Competitive Landscape
3.1 Global Artemisinin Antimalarial Drugs Sales by Manufacturers (2019-2024)
3.2 Global Artemisinin Antimalarial Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Artemisinin Antimalarial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Artemisinin Antimalarial Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Artemisinin Antimalarial Drugs Sales Sites, Area Served, Product Type
3.6 Artemisinin Antimalarial Drugs Market Competitive Situation and Trends
3.6.1 Artemisinin Antimalarial Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Artemisinin Antimalarial Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Artemisinin Antimalarial Drugs Industry Chain Analysis
4.1 Artemisinin Antimalarial Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Artemisinin Antimalarial Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Artemisinin Antimalarial Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2019-2024)
6.3 Global Artemisinin Antimalarial Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Artemisinin Antimalarial Drugs Price by Type (2019-2024)
7 Artemisinin Antimalarial Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Artemisinin Antimalarial Drugs Market Sales by Application (2019-2024)
7.3 Global Artemisinin Antimalarial Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Artemisinin Antimalarial Drugs Sales Growth Rate by Application (2019-2024)
8 Artemisinin Antimalarial Drugs Market Segmentation by Region
8.1 Global Artemisinin Antimalarial Drugs Sales by Region
8.1.1 Global Artemisinin Antimalarial Drugs Sales by Region
8.1.2 Global Artemisinin Antimalarial Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Artemisinin Antimalarial Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Artemisinin Antimalarial Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Artemisinin Antimalarial Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Artemisinin Antimalarial Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Artemisinin Antimalarial Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novartis
9.1.1 Novartis Artemisinin Antimalarial Drugs Basic Information
9.1.2 Novartis Artemisinin Antimalarial Drugs Product Overview
9.1.3 Novartis Artemisinin Antimalarial Drugs Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Artemisinin Antimalarial Drugs SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Sanofi
9.2.1 Sanofi Artemisinin Antimalarial Drugs Basic Information
9.2.2 Sanofi Artemisinin Antimalarial Drugs Product Overview
9.2.3 Sanofi Artemisinin Antimalarial Drugs Product Market Performance
9.2.4 Sanofi Business Overview
9.2.5 Sanofi Artemisinin Antimalarial Drugs SWOT Analysis
9.2.6 Sanofi Recent Developments
9.3 Ajanta
9.3.1 Ajanta Artemisinin Antimalarial Drugs Basic Information
9.3.2 Ajanta Artemisinin Antimalarial Drugs Product Overview
9.3.3 Ajanta Artemisinin Antimalarial Drugs Product Market Performance
9.3.4 Ajanta Artemisinin Antimalarial Drugs SWOT Analysis
9.3.5 Ajanta Business Overview
9.3.6 Ajanta Recent Developments
9.4 Cipla
9.4.1 Cipla Artemisinin Antimalarial Drugs Basic Information
9.4.2 Cipla Artemisinin Antimalarial Drugs Product Overview
9.4.3 Cipla Artemisinin Antimalarial Drugs Product Market Performance
9.4.4 Cipla Business Overview
9.4.5 Cipla Recent Developments
9.5 Ipca
9.5.1 Ipca Artemisinin Antimalarial Drugs Basic Information
9.5.2 Ipca Artemisinin Antimalarial Drugs Product Overview
9.5.3 Ipca Artemisinin Antimalarial Drugs Product Market Performance
9.5.4 Ipca Business Overview
9.5.5 Ipca Recent Developments
9.6 Guilin Medicine
9.6.1 Guilin Medicine Artemisinin Antimalarial Drugs Basic Information
9.6.2 Guilin Medicine Artemisinin Antimalarial Drugs Product Overview
9.6.3 Guilin Medicine Artemisinin Antimalarial Drugs Product Market Performance
9.6.4 Guilin Medicine Business Overview
9.6.5 Guilin Medicine Recent Developments
9.7 GlaxoSmithKline
9.7.1 GlaxoSmithKline Artemisinin Antimalarial Drugs Basic Information
9.7.2 GlaxoSmithKline Artemisinin Antimalarial Drugs Product Overview
9.7.3 GlaxoSmithKline Artemisinin Antimalarial Drugs Product Market Performance
9.7.4 GlaxoSmithKline Business Overview
9.7.5 GlaxoSmithKline Recent Developments
9.8 Mylan Labs
9.8.1 Mylan Labs Artemisinin Antimalarial Drugs Basic Information
9.8.2 Mylan Labs Artemisinin Antimalarial Drugs Product Overview
9.8.3 Mylan Labs Artemisinin Antimalarial Drugs Product Market Performance
9.8.4 Mylan Labs Business Overview
9.8.5 Mylan Labs Recent Developments
9.9 Roche
9.9.1 Roche Artemisinin Antimalarial Drugs Basic Information
9.9.2 Roche Artemisinin Antimalarial Drugs Product Overview
9.9.3 Roche Artemisinin Antimalarial Drugs Product Market Performance
9.9.4 Roche Business Overview
9.9.5 Roche Recent Developments
10 Artemisinin Antimalarial Drugs Market Forecast by Region
10.1 Global Artemisinin Antimalarial Drugs Market Size Forecast
10.2 Global Artemisinin Antimalarial Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Artemisinin Antimalarial Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Artemisinin Antimalarial Drugs Market Size Forecast by Region
10.2.4 South America Artemisinin Antimalarial Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Artemisinin Antimalarial Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Artemisinin Antimalarial Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Artemisinin Antimalarial Drugs by Type (2025-2030)
11.1.2 Global Artemisinin Antimalarial Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Artemisinin Antimalarial Drugs by Type (2025-2030)
11.2 Global Artemisinin Antimalarial Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Artemisinin Antimalarial Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Artemisinin Antimalarial Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
